{"id":88663,"date":"2019-03-14T12:23:47","date_gmt":"2019-03-14T19:23:47","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/03\/33-blood-cancer-patients-have-dramatic-clinical-remission-with-new-t-cell-therapy"},"modified":"2019-03-14T12:23:47","modified_gmt":"2019-03-14T19:23:47","slug":"33-blood-cancer-patients-have-dramatic-clinical-remission-with-new-t-cell-therapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/03\/33-blood-cancer-patients-have-dramatic-clinical-remission-with-new-t-cell-therapy","title":{"rendered":"33 blood-cancer patients have dramatic clinical remission with new T-cell therapy"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/33-blood-cancer-patients-have-dramatic-clinical-remission-with-new-t-cell-therapy2.jpg\"><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"display:none;\" class=\"\" title=\"t-cells surround cancer cells\" src=\"https:\/\/lifeboat.com\/blog.images\/33-blood-cancer-patients-have-dramatic-clinical-remission-with-new-t-cell-therapy2.jpg\" alt=\"\" width=\"445\" height=\"341\"><b><center>Image of a group of killer T cells (green and red) surrounding a cancer cell (blue, center) (credit: NIH)<\/center><\/b><\/p>\n<p>Chinese doctors have reported success with a new type of immunotherapy for multiple myeloma, a blood cancer: 33 out of 35 patients in a clinical trial had clinical remission within two months.<\/p>\n<p>The researchers used a type of <a href=\"https:\/\/en.wikipedia.org\/wiki\/T_cell\" target=\"_blank\">T cell<\/a> called \u201cchimeric antigen receptor (CAR) T.\u201d In a phase I clinical trial in China, the patient\u2019s own T cells were collected, genetically reprogrammed in a lab, and injected back into the patient. The reprogramming involved inserting an artificially designed gene into the T-cell genome, which helped the genetically reprogrammed cells find and destroy cancer cells throughout the body.<\/p>\n<p><!-- Link: <a href=\"http:\/\/www.kurzweilai.net\/33-blood-cancer-patients-have-dramatic-clinical-remission-with-new-t-cell-therapy\">http:\/\/www.kurzweilai.net\/33-blood-cancer-patients-have-dram...ll-therapy<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Image of a group of killer T cells (green and red) surrounding a cancer cell (blue, center) (credit: NIH) Chinese doctors have reported success with a new type of immunotherapy for multiple myeloma, a blood cancer: 33 out of 35 patients in a clinical trial had clinical remission within two months. The researchers used a [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-88663","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/88663","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=88663"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/88663\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=88663"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=88663"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=88663"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}